Latest News

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025
Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

April 2nd 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

David-Alexandre C. Gros, MD, Eledon’s chief executive officer
David-Alexandre Gros, MD, on the Work to Bring Porcine Kidney Transplant to the Clinic

April 2nd 2025

Data Roundup: March 2025 Features Updates from MDA's Conference, an Alzheimer Disease Trial, and More
Data Roundup: March 2025 Features Updates from MDA's Conference, an Alzheimer Disease Trial, and More

April 1st 2025

FDA Activity Recap: March 2025 Features FDA Approvals in Hemophilia, ATTR Amyloidosis, and More
FDA Activity Recap: March 2025 Features FDA Approvals in Hemophilia, ATTR Amyloidosis, and More

April 1st 2025

Video Interviews

Conference Coverage

View All
Natalie Goedeker, CPNP, on Handling Neuromuscular Gene Therapy at Real-World Sites
Natalie Goedeker, CPNP, on Handling Neuromuscular Gene Therapy at Real-World Sites

March 27th 2025

Sarepta’s DMD Gene Therapy Elevidys Demonstrates Manageable Safety Across 5-Year Timespan
Sarepta’s DMD Gene Therapy Elevidys Demonstrates Manageable Safety Across 5-Year Timespan

March 26th 2025

REGENXBIO’s DMD Gene Therapy RGX-202 Generates Microdystrophin Expression in Additional Patients Treated in Phase 1/2 Trial
REGENXBIO’s DMD Gene Therapy RGX-202 Generates Microdystrophin Expression in Additional Patients Treated in Phase 1/2 Trial

March 20th 2025

Genethon’s Gene Therapy GNT0004 Continues to Show Potential in DMD
Genethon’s Gene Therapy GNT0004 Continues to Show Potential in DMD

March 20th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.